In vitro assay and characterization of the farnesylation-dependent prelamin A endoprotease

被引:55
作者
Kilic, F
Dalton, MB
Burrell, SK
Mayer, JP
Patterson, SD
Sinensky, M
机构
[1] E TENNESSEE STATE UNIV,JAMES H QUILLEN COLL MED,DEPT BIOCHEM & MOL BIOL,JOHNSON CITY,TN 37614
[2] UNIV COLORADO,HLTH SCI CTR,DEPT PHYSIOL,DENVER,CO 80262
[3] AMGEN INC,THOUSAND OAKS,CA 91320
关键词
D O I
10.1074/jbc.272.8.5298
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 72-kDa nuclear lamina protein lamin A is synthesized as a 74-kDa farnesylated precursor. Conversion of this precursor to mature lamin A appears to be mediated by a specific endoprotease. Prior studies of overexpressed wild-type and mutant lamin A proteins in cultured cells have indicated that the precursor possesses the typical carboxyl-terminal S-farnesylated, cysteine methyl ester and that farnesylation is required for endoproteolysis to occur. In this report, we describe the synthesis of an S-farnesyl, cysteinyl methyl ester peptide corresponding to the carboxyl-terminal 18 amino acid residues of human prelamin A. This peptide acts as a substrate for the prelamin A endoprotease in vitro, with cleavage of the synthetic peptide at the expected site between Tyr(657) and Leu(658). Endoproteolytic cleavage requires the S-prenylated cysteine methyl ester and, in agreement with transfection studies, is more active with the farnesylated than geranylgeranylated cysteinyl substrate. N-Acetyl farnesyl methyl cysteine is shown to be a noncompetitive inhibitor of the enzyme. Taken together, these observations suggest that there is a specific farnesyl binding site on the enzyme which is not at the active site.
引用
收藏
页码:5298 / 5304
页数:7
相关论文
共 38 条